News
The authors discuss several major pathways involved in breast cancer, including PI3K/Akt/mTOR, RAS/RAF/MEK/ERK, HER2, Wnt/β-catenin, Notch, NF-κB, and the DNA damage response (DDR). These ...
The laboratory is studying small molecules that selectively inhibit the components of RAS-RAF-MEK-ERK and PI3K-AKT-mTOR pathways. These compounds are being used as reagents to define the role of these ...
Hosted on MSN27d
New insights into therapy resistance in breast cancerThe authors discuss several major pathways involved in breast cancer, including PI3K/Akt/mTOR, RAS/RAF/MEK/ERK, HER2, Wnt/β-catenin, Notch, NF-κB, and the DNA damage response (DDR). These ...
We modelled the ability of pathways activated by tyrosine kinase receptors to induce GBM formation in mice with the RCAS/tv-a system, which allows post-natal gene transfer in a cell-type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results